Comparison
Aminotadalafil vs Mirodenafil
Long-acting, well-known analog vs. fast, highly selective newcomer.
Aminotadalafil
PDE5 Inhibitor (Tadalafil Analog)
Mirodenafil
PDE5 Inhibitor
Effectiveness Profile
At a Glance
| Aminotadalafil | Mirodenafil | |
|---|---|---|
| Type | Sexual Health | Sexual Health |
| Legal status | Research | Grey-Market |
| Half-life | ~17.5 hours (extrapolated from tadalafil) | ~2.5 hours |
| Preferred route | Oral | Oral |
| Dose frequency | once-daily | as-needed |
| Beginner dose | 2.5–5 mg | 25–50 mg |
| Intermediate dose | 5–10 mg | 50–100 mg |
| Advanced dose | 10–20 mg | 50–100 mg |
| Cycle length | 0–0 wks | 1–52 wks |
| Bioavailability | — | 75% |
| Time to peak | 2h | 1.25h |
| Active duration | 30h | 4h |
| Storage | Room temperature, dry, protected from light; refrigerate reconstituted or compounded solutions | Room temperature, dry, protected from light |
| PCT required | No | No |
| Ancillaries required | No | No |
| Safe for women | Yes | Yes |
Verdict
Aminotadalafil wins for daily steady-state protocols, sustained blood-pressure management, and cases where a 24–36h window is wanted. Its long half-life mimics the familiar tadalafil playbook with robust PDE5 inhibition and convenience of once-daily dosing.
Mirodenafil wins for fast onset, rapid offset, and minimal PDE6-related sides. Its short half-life is ideal when active duration needs to be tightly controlled or when users want minimal carryover into the next day. The selectivity for PDE5 over PDE6 beats sildenafil and vardenafil for visual side-effect avoidance and is advantageous for users sensitive to flushing, headache, or blue-tint vision.
Pick A or B?
Pick Aminotadalafil if:
- A daily blood-pressure or pump stack (2.5–5mg qd) is the goal
- Long, sustained efficacy is preferred (24–36h window)
- Extrapolatable clinical experience from tadalafil is valued
- Consistency in plasma levels without timing the dose is desired
- Stack includes hair retention agents (finasteride/minoxidil) for scalp microcirculation benefit
Pick Mirodenafil if:
- Short, on-demand protocols with minimal next-day effect are required
- Users want fast onset (Tmax ~1.25h) and short half-life (~2.5h)
- Sensitivity to PDE6 effects (visual changes, flushing) is an issue with sildenafil/vardenafil
- Occasional use and minimal accumulation is a priority
- Sourcing is feasible and legality isn't a barrier in the research setting